Abnormalities in dystrophin protein expression leave both BMD and DMD patients with reduced muscle fiber integrity, leading to life-long, repetitive cycles of myonecrosis and regeneration, endomysial fibrosis (scarring), and eventual fatty replacement of muscle (5, 10). This evidence concerns the gene DMD and Duchenne muscular dystrophy.